HSHHSH Health Technology Supplier Hub
Home › Suppliers › Ortivus › Risk

Ortivus: risk summary

Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.

Financial

Latest full-year results from official filings.

FY2025 revenue SEK 73.4m (-8.7%); net loss SEK 21.9m.

EBITDA SEK -15.9m; raised about SEK 52m in a rights issue.

Researched 8 Nov 2026

Adverse media

Credible news about incidents, disputes, legal action or restructuring in the last 24 months.

No adverse media involving Ortivus found in HSH's search of the last 24 months.

Researched 10 Nov 2026

Regulatory & clinical safety

Recalls, safety notices, regulator action and clinical safety concerns.

No product recalls, MHRA field safety notices or regulator actions involving Ortivus found in HSH's search of the last 24 months.

Researched 10 Nov 2026

Contract performance

Contract delivery, go-lives, terminations and disputes.

Jun 2025: South Western Ambulance Service extended its MobiMed ePR contract by two years to June 2027 (SEK 27.7m); Northern Ireland Ambulance Service also announced a two-year extension that month.

Researched 10 Nov 2026